C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2011
10/27/2011	US20110263659 Analogs of 1-Methylnicotinamide
10/27/2011	US20110263658 Renin inhibitors
10/27/2011	US20110263626 Novel bradykinin b1-antagonists
10/27/2011	US20110263612 Compounds that modulate intracellular calcium
10/27/2011	US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011	US20110263556 New Compounds
10/27/2011	US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011	US20110262025 Cosmetic Compositions and Methods for Maintaining and Improving Barrier Function of the Stratum Corneum and to Reduce the Visible Signs of Aging in Skin
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2380877A1 Pyridine-3-carboxyamide derivative
10/26/2011	EP2380631A1 Heteroaryl derivatives as DGAT1 inhibitors
10/26/2011	EP2379504A2 Coumarin-based compounds
10/26/2011	EP2379503A1 Heterocyclic diketone derivatives with herbicidal action
10/26/2011	EP2379501A1 Method for preparing activated esters
10/26/2011	EP2379472A1 Novel organic compound
10/26/2011	EP2378880A1 Use of 5-pyridin-4yl(1,3)thiazole for treating phytopathogenic fungi
10/26/2011	EP2238110B1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
10/26/2011	EP2125740B1 Fungicide n-(3-phenylpropyl)carboxamide derivatives
10/26/2011	EP2066636B1 5-phenyl-nicotinamide derivatives
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	CN102227438A Novel compound and utilization of same
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102227408A Method for inhibiting dehydrobromination of methyl 2-bromo-3-[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]propionate
10/26/2011	CN102225919A Curcumin analogue and preparation method thereof as well as application of analogue in preparation of Alzheimer disease resisting medicament
10/26/2011	CN102225910A Preparation method of Bronsted acidic ionic liquid based on isonicotinic acid cation
10/26/2011	CN102225909A Preparation method of lansoprazole intermediate
10/26/2011	CN102225908A Micro-scale energetic material and preparation method thereof
10/26/2011	CN102225897A Vesica with ultraviolet-controlled release function as well as preparation method and application thereof
10/26/2011	CN102225896A Ether derivatives of rhein and their therapeutic use
10/26/2011	CN101717365B Method for purification of torasemide and preparation of big crystal form
10/26/2011	CN101676266B Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same
10/25/2011	US8044211 P38 MAP kinase inhibitors
10/25/2011	US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
10/25/2011	US8044074 e.g. 1-(2-Cyclopropylmethoxy-1,2-diphenylethyl)-1H-pyridin-2-one; potassium (K+) channel-blocking agent; atrial arrhythmias, such as atrial fibrillation (AF) or atrial flutter; respiratory disorders, neurodegenerative disorders; anticarcinogenic agent
10/25/2011	US8044048 Derivatives of sulindac, use thereof and preparation thereof
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8044013 Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands
10/20/2011	WO2011130728A1 Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions
10/20/2011	WO2011128261A1 Process for the preparation of 4- {4-[({[4 -chloro-3 -(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-n-methylpyridine-2-carboxamide, its salts and monohydrate
10/20/2011	WO2011127643A1 Pyridone derivatives
10/20/2011	WO2011075210A3 Small molecules that covalently modify transthyretin
10/20/2011	WO2011071881A3 Microwave-assisted synthesis of n-heterocyclic carbene transition metal complexes
10/20/2011	US20110257199 Novel teraryl compounds as antiparasitic agents
10/20/2011	US20110257196 Compounds for treatment of cancer
10/20/2011	US20110257183 Bis-aryl sulfonamides
10/20/2011	US20110257182 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	CA2796238A1 Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl) ph enyl]amino}carbonyl)amino]-3-fluorophenoxy}-n-methylpyridine-2-carboxamide, its salts and monohydrate
10/19/2011	EP2377845A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
10/19/2011	EP2377841A1 Method for producing alcohol compound
10/19/2011	EP2376477A2 Stereoselective synthesis of piperidine derivatives
10/19/2011	EP2376472A1 Process for manufacturing 5-formyl-pyridine-2,3-dicarboxylic acid esters
10/19/2011	EP2376455A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
10/19/2011	EP2376454A2 Inhibitors of diacylglycerol acyltransferase
10/19/2011	EP2376453A1 Processes and intermediates for carbamoylpyridone hiv integrase inhibitors
10/19/2011	EP2376452A2 Novel polymorph of atazanavir sulfate
10/19/2011	EP2376449A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
10/19/2011	EP2376447A2 Dipeptidyl peptidase iv inhibitors
10/19/2011	EP2376431A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
10/19/2011	EP2375898A1 Novel herbicides
10/19/2011	EP2225245B1 N-phenyl-imidazo(1,2-a)pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
10/19/2011	EP2004607B1 (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-N-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof
10/19/2011	EP1899302B1 Phenoxy acetic acids as ppar delta activators
10/19/2011	EP1851210B1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
10/19/2011	CN102224217A Electroluminescent device using the electroluminescent compounds
10/19/2011	CN102224140A Curable composition comprising a thermolatent base
10/19/2011	CN102219743A Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
10/19/2011	CN102219735A Method for preparing 2-sulfydryl-5-bromine-N-pyridine oxide
10/19/2011	CN102219734A Preparation method for nicotinamide
10/19/2011	CN102219733A Method for preparing sorafenib
10/19/2011	CN102219732A Preparation method for 2-chlorine-5-methylpyridine compound
10/19/2011	CN102219731A Production method of pyridine base
10/19/2011	CN102219730A Method for preparing pyridine alkali
10/19/2011	CN101528701B Process for quenching gaseous reaction product containing cyanopyridine
10/18/2011	US8039634 Oxazole hydroxamic acid derivatives and use thereof
10/18/2011	US8039632 2-aminio-pyridine derivatives and their use as potassium channel modulators
10/18/2011	US8039630 Cationic compound, dye compound and method of using the same, and optical information recording medium
10/18/2011	US8039514 Sulfonamide compounds and use thereof
10/18/2011	US8039484 Antidiabetic bicyclic compounds
10/18/2011	US8039473 Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone
10/18/2011	US8039463 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase
10/18/2011	CA2598294C Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
10/18/2011	CA2551167C Aminoalcohol derivatives
10/18/2011	CA2443950C Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/13/2011	WO2011125627A1 Rare-earth metal complex
10/13/2011	WO2011125568A1 Nitrogen-containing heterocyclic compound and method for producing same
10/13/2011	WO2011124307A1 Fluorinating reagents with (perfluoralkyl) fluorophosphate anion
10/13/2011	WO2011079343A3 Substituted pyridines and pyrimidines for the production of cardiomyocyte - like cells
10/13/2011	US20110251397 Method for preparation of 3-methylpyridine
10/13/2011	US20110251394 Novel organic compound
10/13/2011	US20110251393 Helicene derivative, axially asymmetric amino acid, amine or aminoalcohol derivative, perylene derivative or salt thereof, and methods for producing same
10/13/2011	US20110251392 Exo- and diastereo- selective synthesis of himbacine analogs
10/13/2011	US20110251220 Pharmaceutical compositions comprising gamma secretase modulators
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/13/2011	US20110251204 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251196 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251063 Heterocyclic diketone derivatives with herbicidal action
10/13/2011	US20110250616 Electroactive surface-confinable molecules
10/13/2011	CA2795804A1 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
10/13/2011	CA2795748A1 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 633